Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001209191-19-011175

SVP, Head of Global Commercial sold 5,909 shares at $40.00 ($236,360)

  • SVP, Head of Global Commercial acquired 4,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Porter Derrell SVP, Head of Global Commercial 2019-02-15 Option exercise +4,000 $14.30 $57,200 27,597 D
Porter Derrell SVP, Head of Global Commercial 2019-02-15 Sale −5,909 $40.00 $236,360 21,688 D
Derivatives
Porter Derrell SVP, Head of Global Commercial 2019-02-15 Option exercise · Employee Stock Option (Right to Buy) −4,000 109,666 D
Open-market sales · 5,909 sh · avg $40.00 · $236,360
Loading xslF345X03/doc4.xml…